Lukas Andreas Heger, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 7 | 2024 | 2725 | 0.950 |
Why?
|
| Inflammasomes | 2 | 2023 | 495 | 0.780 |
Why?
|
| Thymus Gland | 2 | 2022 | 1267 | 0.770 |
Why?
|
| Cardiology Service, Hospital | 1 | 2021 | 246 | 0.690 |
Why?
|
| Debridement | 1 | 2021 | 492 | 0.660 |
Why?
|
| Tricuspid Valve | 1 | 2021 | 403 | 0.640 |
Why?
|
| Raynaud Disease | 1 | 2018 | 75 | 0.620 |
Why?
|
| Arthritis | 1 | 2023 | 661 | 0.620 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2019 | 354 | 0.600 |
Why?
|
| Spleen | 2 | 2022 | 2362 | 0.600 |
Why?
|
| Endocarditis, Bacterial | 1 | 2021 | 455 | 0.590 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 538 | 0.520 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 627 | 0.490 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 2133 | 0.480 |
Why?
|
| Defibrillators, Implantable | 1 | 2021 | 1440 | 0.410 |
Why?
|
| Blood Platelets | 2 | 2019 | 2509 | 0.350 |
Why?
|
| Flow Cytometry | 6 | 2024 | 5974 | 0.320 |
Why?
|
| Thrombosis | 1 | 2022 | 2968 | 0.320 |
Why?
|
| von Willebrand Factor | 2 | 2022 | 669 | 0.310 |
Why?
|
| Electrocardiography | 1 | 2021 | 6442 | 0.310 |
Why?
|
| Coronary Vessels | 1 | 2019 | 3107 | 0.310 |
Why?
|
| Inflammation | 3 | 2023 | 10637 | 0.290 |
Why?
|
| Oxygen | 1 | 2018 | 4189 | 0.280 |
Why?
|
| Atherosclerosis | 1 | 2022 | 3444 | 0.270 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 2337 | 0.270 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 7658 | 0.260 |
Why?
|
| RNA, Messenger | 1 | 2019 | 13035 | 0.240 |
Why?
|
| Mice, Inbred DBA | 1 | 2023 | 642 | 0.210 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2021 | 88 | 0.200 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 6486 | 0.200 |
Why?
|
| After-Hours Care | 1 | 2021 | 102 | 0.190 |
Why?
|
| Heart Failure | 1 | 2023 | 10895 | 0.170 |
Why?
|
| Receptors, IgG | 1 | 2022 | 582 | 0.170 |
Why?
|
| Staurosporine | 1 | 2019 | 251 | 0.160 |
Why?
|
| Extracellular Space | 1 | 2019 | 595 | 0.150 |
Why?
|
| Germany | 1 | 2019 | 862 | 0.150 |
Why?
|
| Cell Separation | 1 | 2022 | 1751 | 0.140 |
Why?
|
| Immunity | 1 | 2023 | 1014 | 0.140 |
Why?
|
| Workflow | 1 | 2021 | 847 | 0.140 |
Why?
|
| Monocytes | 1 | 2024 | 2596 | 0.120 |
Why?
|
| Humans | 19 | 2023 | 744366 | 0.120 |
Why?
|
| Proteome | 1 | 2024 | 1798 | 0.120 |
Why?
|
| Receptor, erbB-2 | 1 | 2023 | 2417 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2019 | 3751 | 0.110 |
Why?
|
| Immunologic Factors | 1 | 2021 | 1580 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2022 | 53290 | 0.100 |
Why?
|
| Histones | 1 | 2022 | 2598 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3590 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2022 | 23336 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.090 |
Why?
|
| Neutrophils | 1 | 2022 | 3721 | 0.090 |
Why?
|
| Coronary Angiography | 1 | 2021 | 4576 | 0.090 |
Why?
|
| Proteomics | 1 | 2022 | 3638 | 0.090 |
Why?
|
| Skin | 1 | 2022 | 4372 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 1354 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 6171 | 0.080 |
Why?
|
| Cytokines | 1 | 2023 | 7323 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 14723 | 0.070 |
Why?
|
| Myocardial Infarction | 2 | 2018 | 11718 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2023 | 11486 | 0.070 |
Why?
|
| Registries | 1 | 2021 | 8091 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15078 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 9274 | 0.060 |
Why?
|
| Aged | 4 | 2021 | 163288 | 0.060 |
Why?
|
| Male | 6 | 2021 | 350115 | 0.060 |
Why?
|
| Female | 6 | 2023 | 380193 | 0.060 |
Why?
|
| Apoptosis | 1 | 2019 | 9724 | 0.060 |
Why?
|
| Middle Aged | 4 | 2021 | 213390 | 0.050 |
Why?
|
| Cross-Priming | 1 | 2022 | 82 | 0.050 |
Why?
|
| Mice | 3 | 2024 | 81201 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2021 | 77460 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21748 | 0.050 |
Why?
|
| Incidence | 1 | 2019 | 20952 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2023 | 23404 | 0.040 |
Why?
|
| Time Factors | 1 | 2021 | 40075 | 0.040 |
Why?
|
| Glycosylation | 1 | 2022 | 1128 | 0.040 |
Why?
|
| Animals | 4 | 2024 | 168768 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2022 | 810 | 0.040 |
Why?
|
| Hemolysis | 1 | 2019 | 420 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 1143 | 0.040 |
Why?
|
| Platelet Count | 1 | 2019 | 780 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 57776 | 0.030 |
Why?
|
| Risk Factors | 1 | 2021 | 72296 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15160 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 4561 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2019 | 2455 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 3799 | 0.020 |
Why?
|
| Acute Disease | 1 | 2017 | 7147 | 0.020 |
Why?
|
| Kidney | 1 | 2022 | 7184 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9445 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8319 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 16367 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2019 | 19233 | 0.010 |
Why?
|
| Models, Biological | 1 | 2019 | 9584 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 19905 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 12073 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56429 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 214052 | 0.000 |
Why?
|